Comparative analysis of the extracellular proteomes of two clostridium sordellii strains exhibiting contrasting virulence

Anaerobe

Volumn 16, Issue 4, 2010, Pages 454-460

  Kachman, Maureen T ^a   Hurley, Mary C ^a   Thiele, Teri ^b   Srinivas, Geetha ^b   Aronoff, David M ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

2DE; Anaerobes; Clostridium infection; Lethal toxin; Mass spectrometry; Toxic shock syndrome

Indexed keywords

BACTERIAL PROTEIN; CLOSTRIDIUM TOXIN; FERREDOXIN NITRITE REDUCTASE; FORMATE ACETYLTRANSFERASE; LETHAL TOXIN; N ACETYLMURAMOYLALANINE AMIDASE; PROTEOME; PURINE NUCLEOSIDE PHOSPHORYLASE; TRANSLATION ELONGATION FACTOR G; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL VIRULENCE; CLOSTRIDIUM SORDELLII; COMPARATIVE STUDY; CONTROLLED STUDY; GENE OVEREXPRESSION; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; SEQUENCE HOMOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM SORDELLII; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; MASS SPECTROMETRY; PROTEOME; VIRULENCE FACTORS;

CLOSTRIDIUM; CLOSTRIDIUM SORDELLII; MUS; RODENTIA;

EID: 77956060898     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2010.03.004     Document Type: Article

References (43)

1. Aldape M.J., Bryant A.E., Stevens D.L. Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis 2006, 43:1436-1446.
2. Bangsberg D.R., Rosen J.I., Aragon T., Campbell A., Weir L., Perdreau-Remington F. Clostridial myonecrosis cluster among injection drug users: a molecular epidemiology investigation. Arch Intern Med 2002, 162:517-522.
3. Dunbar N.M., Harruff R.C. Necrotizing fasciitis: manifestations, microbiology and connection with black tar heroin. J Forensic Sci 2007, 52:920-923.
4. Kimura A.C., Higa J.I., Levin R.M., Simpson G., Vargas Y., Vugia D.J. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis 2004, 38:e87-e91.
5. Bitti A., Mastrantonio P., Spigaglia P., Urru G., Spano A.I., Moretti G., et al. A fatal postpartum Clostridium sordellii associated toxic shock syndrome. J Clin Pathol 1997, 50:259-260.
6. Fischer M., Bhatnagar J., Guarner J., Reagan S., Hacker J.K., Van Meter S.H., et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med 2005, 353:2352-2360.
7. Kainer M.A., Linden J.V., Whaley D.N., Holmes H.T., Jarvis W.R., Jernigan D.B., et al. Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med 2004, 350:2564-2571.
8. Sosolik R.C., Savage B.A., Vaccarello L. Clostridium sordellii toxic shock syndrome: a case report and review of the literature. Infect Dis Obstet Gynecol 1996, 4:31-35.
9. McGregor J.A., Soper D.E., Lovell G., Todd J.K. Maternal deaths associated with Clostridium sordellii infection. Am J Obstet Gynecol 1989, 161:987-995.
10. Aronoff D.M., Ballard J.D. Clostridium sordellii toxic shock syndrome. Lancet Infect Dis 2009, 9:725-726.
11. Voth D.E., Martinez O.V., Ballard J.D. Variations in lethal toxin and cholesterol-dependent cytolysin production correspond to differences in cytotoxicity among strains of Clostridium sordellii. FEMS Microbiol Lett 2006, 259:295-302.
12. Macfarlane M.G. The biochemistry of bacterial toxins: 3. The identification and immunological relations of lecithinases present in Clostridium oedematiens and Clostridium sordellii toxins. Biochem J 1948, 42:590-595.
13. Roggentin P., Berg W., Schauer R. Purification and characterization of sialidase from Clostridium sordellii G12. Glycoconjugate 1987, 4:349-359.
14. Arseculeratne S.N., Panabokke R.G., Wijesundera S. The toxins responsible for the lesions of Clostridium sordellii gas gangrene. J Med Microbiol 1969, 2:37-53.
15. Martinez R.D., Wilkins T.D. Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin). Infect Immun 1988, 56:1215-1221.
16. Popoff M.R. Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin. Infect Immun 1987, 55:35-43.
17. Popoff M.R., Guillou J.P., Carlier J.P. Taxonomic position of lecithinase-negative strains of Clostridium sordellii. J Gen Microbiol 1985, 131:1697-1703.
18. Hao Y., Senn T., Opp J., Young V.B., Thiele T., Srinivas G., et al. Lethal toxin is a critical determinant of rapid mortality in rodent models of Clostridium sordellii endometritis. Anaerobe 2010, 16(2):155-160.
19. Geny B., Khun H., Fitting C., Zarantonelli L., Mazuet C., Cayet N., et al. Clostridium sordellii lethal toxin kills mice by inducing a major increase in lung vascular permeability. Am J Pathol 2007, 170:1003-1017.
20. 2-terminal kinase pathway by the lethal toxin from Clostridium sordellii, TcsL-82, occurs independently of the toxin intrinsic enzymatic activity and facilitates small GTPase glucosylation. Cell Microbiol 2009, 11:1102-1113.
21. Aronoff D.M., Hao Y., Chung J., Coleman N., Lewis C., Peres C.M., et al. Misoprostol impairs female reproductive tract innate immunity against Clostridium sordellii. J Immunol 2008, 180:8220-8230.
22. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288:306-313.
23. Xie H.Y., Xia W.L., Zhang C.C., Wu L.M., Ji H.F., Cheng Y., et al. Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment. Acta Pharmacol Sin 2007, 28:975-984.
24. Muto C.A., Pokrywka M., Shutt K., Mendelsohn A.B., Nouri K., Posey K., et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005, 26:273-280.
25. Mukherjee K., Karlsson S., Burman L.G., Akerlund T. Proteins released during high toxin production in Clostridium difficile. Microbiology 2002, 148:2245-2253.
26. Alam S.I., Bansod S., Kumar R.B., Sengupta N., Singh L. Differential proteomic analysis of Clostridium perfringens ATCC13124; identification of dominant, surface and structure associated proteins. BMC Microbiol 2009, 9:162.
27. Lawley T.D., Croucher N.J., Yu L., Clare S., Sebaihia M., Goulding D., et al. Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores. J Bacteriol 2009, 191:5377-5386.
28. Sullivan L., Bennett G.N. Proteome analysis and comparison of Clostridium acetobutylicum ATCC 824 and Spo0A strain variants. J Ind Microbiol Biotechnol 2006, 33:298-308.
29. Williams T.I., Combs J.C., Lynn B.C., Strobel H.J. Proteomic profile changes in membranes of ethanol-tolerant Clostridium thermocellum. Appl Microbiol Biotechnol 2007, 74:422-432.
30. Wright A., Wait R., Begum S., Crossett B., Nagy J., Brown K., et al. Proteomic analysis of cell surface proteins from Clostridium difficile. Proteomics 2005, 5:2443-2452.
31. Sekiguchi S., Seki S., Ishimoto M. Purification and some properties of nitrite reductase from Clostridium perfringens. J Biochem 1983, 94:1053-1059.
32. Weidner G., Sawers G. Molecular characterization of the genes encoding pyruvate formate-lyase and its activating enzyme of Clostridium pasteurianum. J Bacteriol 1996, 178:2440-2444.
33. Karlin S., Theriot J., Mrazek J. Comparative analysis of gene expression among low G+C gram-positive genomes. Proc Natl Acad Sci U S A 2004, 101:6182-6187.
34. Nakamura S., Nakashio S., Mikawa M., Yamakawa K., Okumura S., Nishida S. Antimicrobial susceptibility of Clostridium difficile from different sources. Microbiol Immunol 1982, 26:25-30.
35. Savelsbergh A., Rodnina M.V., Wintermeyer W. Distinct functions of elongation factor G in ribosome recycling and translocation. RNA 2009, 15:772-780.
36. Consortium T.U. The Universal Protein Resource (UniProt) 2009. Nucleic Acids Res 2009, 37:D169-D174.
37. Vollmer W., Joris B., Charlier P., Foster S. Bacterial peptidoglycan (murein) hydrolases. FEMS Microbiol Rev 2008, 32:259-286.
38. Antelmann H., Tjalsma H., Voigt B., Ohlmeier S., Bron S., van Dijl J.M., et al. A proteomic view on genome-based signal peptide predictions. Genome Res 2001, 11:1484-1502.
39. Calabi E., Ward S., Wren B., Paxton T., Panico M., Morris H., et al. Molecular characterization of the surface layer proteins from Clostridium difficile. Mol Microbiol 2001, 40:1187-1199.
40. Bruggemann H., Baumer S., Fricke W.F., Wiezer A., Liesegang H., Decker I., et al. The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc Natl Acad Sci U S A 2003, 100:1316-1321.
41. Eidhin D.N., Ryan A.W., Doyle R.M., Walsh J.B., Kelleher D. Sequence and phylogenetic analysis of the gene for surface layer protein, slpA, from 14 PCR ribotypes of Clostridium difficile. J Med Microbiol 2006, 55:69-83.
42. Driessen A.J., Nouwen N. Protein translocation across the bacterial cytoplasmic membrane. Annu Rev Biochem 2008, 77:643-667.
43. Bettegowda C., Huang X., Lin J., Cheong I., Kohli M., Szabo S.A., et al. The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT. Nat Biotechnol 2006, 24:1573-1580.